Product custom-nanocomposites-fluorescent-labeled-nanocomposites

Home > products > custom-nanocomposites> fluorescent-labeled-nanocomposites

Catalog	name	Description	price
R-M1-8762	LNP-cy5/RGD,100nm	Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy).	price>
R-M1-8763	FITC-Ti3C2,200nm-1000nm	FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities.	price>
R-M1-cs8773	CY7@EScu@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments.	price>
R-M1-cs8774	Cyanine7@ES@ROSlnp-YSAYPDSVPMMS	ROS responsive liposome nanoparticles encapsulate ES and CY7 surface modified peptides.By encapsulating ES and CY7 surface-modified peptides within the ROS-responsive liposome nanoparticles, it is possible to achieve targeted delivery or imaging in ROS-rich environments. The surface modifications on the peptides can facilitate specific interactions with the target cells or tissues, while the ROS-responsive nature of the liposomes regulates the release of the peptides in response to the local ROS levels.	price>
R-M1-cs8799	ROS responsive liposomes loaded with CE6	ROS responsive liposomes loaded with CE6 (chlorin e6) are a type of drug delivery system designed to specifically target and respond to reactive oxygen species (ROS) in the body. Upon destabilization, the liposomes release the CE6 into the surrounding tissues. The released CE6 can then undergo a photochemical reaction when activated by specific wavelengths of light, generating highly reactive singlet oxygen species. This localized generation of singlet oxygen can induce cell death, making it particularly suitable for photodynamic therapy (PDT) applications. By specifically targeting and releasing the CE6 in ROS-rich areas, ROS responsive liposomes loaded with CE6 can enhance the therapeutic efficacy of photodynamic therapy while minimizing off-target effects.	price>
R-M1-9151	Cy5-azide modified SiO2,800nm	Cy5-azide modified SiO2 refers to silicon dioxide (SiO2) nanoparticles that have been modified with the organic dye Cy5 and functionalized with an azide group.It could be used in applications such as fluorescent imaging, drug delivery, or bioconjugation, where the azide group can participate in specific chemical reactions to link the modified nanoparticles to other functional molecules or surfaces.	price>
R-M1-9169	Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin	Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin/Ce6 modified polydopamine encapsulates MIL-101 loaded gemcitabine and cisplatin from ruixi.We can accept customized products. Ce6: This likely refers to Chlorin e6, a photosensitizer used in photodynamic therapy (PDT) for the treatment of cancer. Ce6 absorbs light and transfers energy to molecular oxygen, creating reactive oxygen species that can destroy nearby cancer cells. Polydopamine: This is a biocompatible and adhesive polymer derived from dopamine. It has been used as a coating material for drug delivery systems due to its versatile surface functionalization and biocompatibility. MIL-101: This is a metal-organic framework (MOF), a class of materials with high porosity and surface area. MIL-101 can be used to encapsulate and deliver drugs due to its porous nature and controllable pore sizes. Gemcitabine: It is a chemotherapy medication used to treat various types of cancers, including bladder cancer, breast cancer, ovarian cancer, and non-small cell lung cancer. Cisplatin: This is a chemotherapy medication used to treat various types of cancers, including testicular, ovarian, bladder, and lung cancers.	price>
R-M1-8671	Folic acid modified cationic liposome encapsulation plasmid and ICG (100-200nm)	Folic acid modified cationic liposome encapsulation of plasmid and ICG (100-200nm) from ruixibio.Cationic liposomes are lipid-based nanoparticles with a positive charge due to the presence of cationic lipids. These nanoparticles are commonly used for the encapsulation and delivery of genetic material, such as plasmid DNA, to target cells for gene therapy applications.In this case, the cationic liposomes are modified with folic acid, which acts as a targeting ligand. Folic acid receptors are often overexpressed on the surface of certain cancer cells, providing a way to specifically target these cells. By modifying the liposomes with folic acid, they can enhance cellular uptake by cancer cells that express higher levels of folate receptors.The plasmid DNA within the liposomes may contain therapeutic genes or other genetic material that can be delivered to the target cells for specific applications, such as gene therapy. Meanwhile, the indocyanine green (ICG) dye serves as both a fluorescent marker and a near-infrared (NIR) imaging agent that can provide real-time monitoring and imaging of the targeted cells.	price>
R-M1-8673	Liposome encapsulated Ce6	Liposome encapsulated Ce6/Liposome@Ce6/Liposome encapsulated chlorin e6/Chlorin e6 (Ce6)-loaded liposome can be used for in vitro and in vivo experiments, as well as research on drug delivery.Because its Chlororin e6 (Ce6) is a photosensitizer material, it can have therapeutic effects on pathogens. In order to improve the efficacy of photosensitizers, various drug delivery systems have been developed. In these carrier systems, liposomes demonstrate their PDT efficacy and safety in delivering photosensitizers.	price>
R-M1-8682	ICG@liposome-cRGD,100nm	ICG@liposome-cRGD is a multifunctional complex that combines the imaging capabilities of ICG, the drug delivery properties of liposomes, and the targeting ability of cRGD peptides. Its potential applications in biomedical research include targeted imaging, drug delivery, and theranostics (combined therapy and diagnostics).	price>

...